Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

Cytek Biosciences (CTKB) Gross Profit (2020 - 2026)

Cytek Biosciences filings provide 6 years of Gross Profit readings, the most recent being $32.9 million for Q4 2025.

  • On a quarterly basis, Gross Profit fell 2.28% to $32.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $104.5 million, a 5.98% decrease, with the full-year FY2025 number at $104.5 million, down 5.98% from a year prior.
  • Gross Profit hit $32.9 million in Q4 2025 for Cytek Biosciences, up from $27.6 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $33.7 million in Q4 2024 to a low of $14.5 million in Q1 2021.
  • Median Gross Profit over the past 5 years was $25.0 million (2022), compared with a mean of $25.3 million.
  • Biggest five-year swings in Gross Profit: surged 138.75% in 2021 and later dropped 12.41% in 2025.
  • Cytek Biosciences' Gross Profit stood at $23.6 million in 2021, then increased by 24.28% to $29.4 million in 2022, then increased by 12.51% to $33.0 million in 2023, then rose by 1.83% to $33.7 million in 2024, then fell by 2.28% to $32.9 million in 2025.
  • The last three reported values for Gross Profit were $32.9 million (Q4 2025), $27.6 million (Q3 2025), and $23.9 million (Q2 2025) per Business Quant data.